Alcohol consumption in patients with primary sclerosing cholangitis

Table 1 Clinical characteristics and drinking habits of 96 patients with primary sclerosing cholangitis

	Mean (range)
Age at inclusion (yr)	47 (22-75)
Male sex	63/96
Duration of primary sclerosing cholangitis (yr)	12 (0-30)
Age at primary sclerosing cholangitis diagnosis (yr)	35 (11-65)
Fibroscan value (kPa)	11.1 (2.8-48)
Undergone orthotopic liver transplantation, n (%)	12 (12.5)
Bilirubin (μmol/L)	15.3 (3-82)
Alkaline phosphatase (μkat/L)	2.66 (0.5-12.4)
Phosphatidylethanol (μmol/L)	0.28 (0.1-8.4)
Carbohydrate-deficient transferrin (%)	1.01 (0.5-3)
Body mass index (kg/m2)	24.1 (17.2-34.3)
Inflammatory bowel disease (%)	73/96 (76)
Smoking-current user, n (%)	4 (4.2)
Smoking-ex user, n (%)	16 (16.7)
Smoking-never used, n (%)	76 (79.2)
Lifetime drinking habits
Age at first alcohol intake (yr)	17 (12-28)
Lifetime alcohol intake (unit)	3882 (0-20 270)
Yearly alcohol intake, total (unit)	137 (0-1180)
Yearly alcohol intake, before diagnosis (unit)	109 (0-674)
Yearly alcohol intake, after diagnosis (unit)	134 (0-1110)
Total occasions of binge-drinking	294 (0-4054)
Yearly occasions of binge-drinking, total	11.3 (0-165)
Yearly occasions of binge-drinking, before diagnosis	12.0 (0-295)
Yearly occasions of binge-drinking, after diagnosis	8.0 (0-83)

Normal range, laboratory values. Bilirubin: < 26 μmol/L; Alkaline phosphatase: < 1.9 μkat/L; Phosphatidylethanol: < 1.0 μmol/L; Carbohydrate-deficient transferrin: < 2.0%.